Literature DB >> 7881103

Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer.

M J Ellis1, C Singer, A Hornby, A Rasmussen, K J Cullen.   

Abstract

The prominent 'desmoplastic' or stromal reaction seen in many invasive breast carcinomas lead to early speculation that stromal cells play a role in breast cancer pathogenesis. Experimental evidence now supports this hypothesis and interactions between stromal cells and epithelial cells appear to be important for both normal mammary development and neoplasia. The identification of genes that are selectively expressed in the stroma of malignant breast lesions has recently provided new insights into the molecular basis of stromal-epithelial interactions. Stromally expressed genes include growth factors, proteases and extracellular matrix proteins, all biological activities with potential roles in malignant progression. Investigations discussed here concern the nature of the paracrine signals provided by malignant epithelial cells that activate changes in stromal gene expression, the effect that the stromally derived factors have on the behavior of malignant epithelial cells and the identification of novel factors and receptors in either stroma or epithelia that contribute to their mutual interactions. These questions will be addressed in the context of this laboratory's studies on insulin-like growth factors, as these molecules show marked differences in stromal expression between benign and malignant breast tissue and thus provide a useful paradigm for investigations into the paracrine environment of an evolving breast tumor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7881103     DOI: 10.1007/bf00666158

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  66 in total

Review 1.  Anterior pituitary development: short tales from dwarf mice.

Authors:  J W Voss; M G Rosenfeld
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.

Authors:  R J Daly; W H Harris; D Y Wang; P D Darbre
Journal:  Cell Growth Differ       Date:  1991-09

3.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.

Authors:  R Chiquet-Ehrismann; P Kalla; C A Pearson
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

4.  Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I.

Authors:  T Thorsen; H Lahooti; M Rasmussen; A Aakvaag
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

5.  Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.

Authors:  D Yee; F R Morales; T C Hamilton; D D Von Hoff
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

6.  The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus.

Authors:  D P Barlow; R Stöger; B G Herrmann; K Saito; N Schweifer
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

7.  Parental genomic imprinting of the human IGF2 gene.

Authors:  N Giannoukakis; C Deal; J Paquette; C G Goodyer; C Polychronakos
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

8.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

Authors:  I A Drummond; S L Madden; P Rohwer-Nutter; G I Bell; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

9.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

Review 10.  Hormone families: pancreatic hormones and homologous growth factors.

Authors:  T L Blundell; R E Humbel
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

View more
  17 in total

Review 1.  Insulin-like growth factors in milk and mammary gland.

Authors:  C G Prosser
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

3.  Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture.

Authors:  C Gache; Y Berthois; P M Martin; S Saez
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

4.  Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice.

Authors:  Yingjie Wu; Hui Sun; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

5.  The role of the tumor microenvironment in regulating angiogenesis.

Authors:  Randolph S Watnick
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

6.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

7.  Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.

Authors:  S Rinaldi; C Biessy; M Hernandez; F Lesueur; I dos-Santos-Silva; M S Rice; M Lajous; R Lopez-Ridaura; G Torres-Mejía; I Romieu
Journal:  Int J Cancer       Date:  2013-10-05       Impact factor: 7.396

8.  H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression.

Authors:  E Adriaenssens; L Dumont; S Lottin; D Bolle; A Leprêtre; A Delobelle; F Bouali; T Dugimont; J Coll; J J Curgy
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 9.  Breast cancer: further metabolic-endocrine risk markers?

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.